Cargando…

Use and perception of telemedicine in people with type 1 diabetes during the COVID‐19 pandemic—Results of a global survey

INTRODUCTION: The COVID‐19 pandemic has forced rapid reconsideration as to the way in which health care is delivered. One potential means to provide care while avoiding unnecessary person‐to‐person contact is to offer remote services (telemedicine). This study aimed to (1) gather real‐time informati...

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, Sam N., Fontana, Federico Y., Züger, Thomas, Laimer, Markus, Stettler, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831200/
https://www.ncbi.nlm.nih.gov/pubmed/33532617
http://dx.doi.org/10.1002/edm2.180
_version_ 1783641586252382208
author Scott, Sam N.
Fontana, Federico Y.
Züger, Thomas
Laimer, Markus
Stettler, Christoph
author_facet Scott, Sam N.
Fontana, Federico Y.
Züger, Thomas
Laimer, Markus
Stettler, Christoph
author_sort Scott, Sam N.
collection PubMed
description INTRODUCTION: The COVID‐19 pandemic has forced rapid reconsideration as to the way in which health care is delivered. One potential means to provide care while avoiding unnecessary person‐to‐person contact is to offer remote services (telemedicine). This study aimed to (1) gather real‐time information on the use and perception of telemedicine in people living with type 1 diabetes and (2) assess the challenges, such as restricted access to health care and/or medical supplies. METHODS: An anonymous questionnaire was widely distributed between 24 March and 5 May 2020 using an open‐access web‐based platform. Data were analysed descriptively, and results were stratified according to age, sex and HbA(1c). RESULTS: There were 7477 survey responses from individuals in 89 countries. Globally, 30% reported that the pandemic had affected their healthcare access due to cancelled physical appointments with their healthcare providers. Thirty‐two per cent reported no fundamental change in their medical follow‐up during this period, with 9% stating that no personal contact was established with their doctors over the duration of the study. Twenty‐eight per cent received remote care through telephone (72%) or video‐calls (28%). Of these, 86% found remote appointments useful and 75% plan to have remote appointments in the future. Glucose control, indicated by HbA(1c), was positively associated with positive perception of telemedicine. In males, 45% of respondents with an HbA(1c) > 9% rated telemedicine not useful compared to those with lower HbA(1c,) while 20% of females with an HbA(1c) > 9% rated it not useful (χ(2) = 14.2, P = .0016). CONCLUSION: Remote appointments have largely been perceived as positive in people with type 1 diabetes with the majority (75%) stating that they would consider remote appointments beyond the pandemic. Age and level of education do not appear to influence perception of telemedicine, whereas poor glucose control, particularly in males, seems to negatively affect perception.
format Online
Article
Text
id pubmed-7831200
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78312002021-02-01 Use and perception of telemedicine in people with type 1 diabetes during the COVID‐19 pandemic—Results of a global survey Scott, Sam N. Fontana, Federico Y. Züger, Thomas Laimer, Markus Stettler, Christoph Endocrinol Diabetes Metab Original Research Articles INTRODUCTION: The COVID‐19 pandemic has forced rapid reconsideration as to the way in which health care is delivered. One potential means to provide care while avoiding unnecessary person‐to‐person contact is to offer remote services (telemedicine). This study aimed to (1) gather real‐time information on the use and perception of telemedicine in people living with type 1 diabetes and (2) assess the challenges, such as restricted access to health care and/or medical supplies. METHODS: An anonymous questionnaire was widely distributed between 24 March and 5 May 2020 using an open‐access web‐based platform. Data were analysed descriptively, and results were stratified according to age, sex and HbA(1c). RESULTS: There were 7477 survey responses from individuals in 89 countries. Globally, 30% reported that the pandemic had affected their healthcare access due to cancelled physical appointments with their healthcare providers. Thirty‐two per cent reported no fundamental change in their medical follow‐up during this period, with 9% stating that no personal contact was established with their doctors over the duration of the study. Twenty‐eight per cent received remote care through telephone (72%) or video‐calls (28%). Of these, 86% found remote appointments useful and 75% plan to have remote appointments in the future. Glucose control, indicated by HbA(1c), was positively associated with positive perception of telemedicine. In males, 45% of respondents with an HbA(1c) > 9% rated telemedicine not useful compared to those with lower HbA(1c,) while 20% of females with an HbA(1c) > 9% rated it not useful (χ(2) = 14.2, P = .0016). CONCLUSION: Remote appointments have largely been perceived as positive in people with type 1 diabetes with the majority (75%) stating that they would consider remote appointments beyond the pandemic. Age and level of education do not appear to influence perception of telemedicine, whereas poor glucose control, particularly in males, seems to negatively affect perception. John Wiley and Sons Inc. 2020-08-29 /pmc/articles/PMC7831200/ /pubmed/33532617 http://dx.doi.org/10.1002/edm2.180 Text en © 2020 The Authors. Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Articles
Scott, Sam N.
Fontana, Federico Y.
Züger, Thomas
Laimer, Markus
Stettler, Christoph
Use and perception of telemedicine in people with type 1 diabetes during the COVID‐19 pandemic—Results of a global survey
title Use and perception of telemedicine in people with type 1 diabetes during the COVID‐19 pandemic—Results of a global survey
title_full Use and perception of telemedicine in people with type 1 diabetes during the COVID‐19 pandemic—Results of a global survey
title_fullStr Use and perception of telemedicine in people with type 1 diabetes during the COVID‐19 pandemic—Results of a global survey
title_full_unstemmed Use and perception of telemedicine in people with type 1 diabetes during the COVID‐19 pandemic—Results of a global survey
title_short Use and perception of telemedicine in people with type 1 diabetes during the COVID‐19 pandemic—Results of a global survey
title_sort use and perception of telemedicine in people with type 1 diabetes during the covid‐19 pandemic—results of a global survey
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831200/
https://www.ncbi.nlm.nih.gov/pubmed/33532617
http://dx.doi.org/10.1002/edm2.180
work_keys_str_mv AT scottsamn useandperceptionoftelemedicineinpeoplewithtype1diabetesduringthecovid19pandemicresultsofaglobalsurvey
AT fontanafedericoy useandperceptionoftelemedicineinpeoplewithtype1diabetesduringthecovid19pandemicresultsofaglobalsurvey
AT zugerthomas useandperceptionoftelemedicineinpeoplewithtype1diabetesduringthecovid19pandemicresultsofaglobalsurvey
AT laimermarkus useandperceptionoftelemedicineinpeoplewithtype1diabetesduringthecovid19pandemicresultsofaglobalsurvey
AT stettlerchristoph useandperceptionoftelemedicineinpeoplewithtype1diabetesduringthecovid19pandemicresultsofaglobalsurvey